JP2010521418A5 - - Google Patents

Download PDF

Info

Publication number
JP2010521418A5
JP2010521418A5 JP2009539559A JP2009539559A JP2010521418A5 JP 2010521418 A5 JP2010521418 A5 JP 2010521418A5 JP 2009539559 A JP2009539559 A JP 2009539559A JP 2009539559 A JP2009539559 A JP 2009539559A JP 2010521418 A5 JP2010521418 A5 JP 2010521418A5
Authority
JP
Japan
Prior art keywords
antibody
pharmaceutical composition
amino acid
acid sequence
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009539559A
Other languages
English (en)
Japanese (ja)
Other versions
JP4865868B2 (ja
JP2010521418A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2008/055344 external-priority patent/WO2008114876A1/en
Publication of JP2010521418A publication Critical patent/JP2010521418A/ja
Publication of JP2010521418A5 publication Critical patent/JP2010521418A5/ja
Application granted granted Critical
Publication of JP4865868B2 publication Critical patent/JP4865868B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009539559A 2007-03-14 2008-03-14 悪性中皮種の治療方法 Active JP4865868B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89478607P 2007-03-14 2007-03-14
US60/894,786 2007-03-14
PCT/JP2008/055344 WO2008114876A1 (en) 2007-03-14 2008-03-14 A method of treating malignant mesothelioma

Publications (3)

Publication Number Publication Date
JP2010521418A JP2010521418A (ja) 2010-06-24
JP2010521418A5 true JP2010521418A5 (cg-RX-API-DMAC7.html) 2011-03-03
JP4865868B2 JP4865868B2 (ja) 2012-02-01

Family

ID=39765975

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009539559A Active JP4865868B2 (ja) 2007-03-14 2008-03-14 悪性中皮種の治療方法

Country Status (5)

Country Link
US (2) US20100135993A1 (cg-RX-API-DMAC7.html)
EP (1) EP2131863A4 (cg-RX-API-DMAC7.html)
JP (1) JP4865868B2 (cg-RX-API-DMAC7.html)
CA (1) CA2680368A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008114876A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010099918A1 (en) * 2009-03-06 2010-09-10 Klaus Tschira Stiftung Ggmbh Pharmaceutical composition and method for identifying a cancerous and/or an inflammatory disease in a patient
WO2012024519A2 (en) * 2010-08-18 2012-02-23 Theresa Deisher Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
JP2015030666A (ja) 2013-07-31 2015-02-16 学校法人順天堂 抗ヒトｃｄ２６モノクローナル抗体又はその抗原結合性断片
RU2020142534A (ru) * 2015-09-11 2021-02-01 И' с АК Ко., Лтд. Композиция для лечения рака, объединяющая анти-cd26 антитело и другое противораковое средство
US10282369B2 (en) * 2017-03-08 2019-05-07 Centri Technology, Inc. Fast indexing and searching of encoded documents
JP7064203B2 (ja) * 2018-03-16 2022-05-10 学校法人順天堂 抗ヒトｃｄ２６モノクローナル抗体
WO2022066847A1 (en) * 2020-09-24 2022-03-31 Alnylam Pharmaceuticals, Inc. Dipeptidyl peptidase 4 (dpp4) irna compositions and methods of use thereof
KR20240007230A (ko) 2021-05-13 2024-01-16 아디에네 에스.에이. 피부근염을 치료하는 방법
MX2023012633A (es) * 2021-05-13 2023-11-09 Adienne S A Metodos de tratamiento de la enfermedad de injerto contra hospedero.
JP2022184105A (ja) * 2021-05-31 2022-12-13 ワイズ・エー・シー株式会社 抗ｃｄ２６抗体と免疫チェックポイント阻害剤との併用療法
CN116023491A (zh) * 2021-10-25 2023-04-28 江苏众红生物工程创药研究院有限公司 抗cd26抗体及其应用
CN116549629A (zh) * 2022-01-30 2023-08-08 江苏众红生物工程创药研究院有限公司 Cd45作为生物标志物在筛查cd26抗体或其衍生物治疗肿瘤有效性和精准性中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2446806A1 (en) * 2001-05-11 2002-11-21 Board Of Regents, The University Of Texas System Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26
EP1395274A2 (en) * 2001-05-22 2004-03-10 Duke University Compositions and methods for inhibiting metastasis
RU2486204C2 (ru) * 2005-07-22 2013-06-27 Уай'З Терапьютикс Ко., Лтд. Антитела против сd26 и способы их применения

Similar Documents

Publication Publication Date Title
JP2010521418A5 (cg-RX-API-DMAC7.html)
Shieh et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States
CN104593332B (zh) 一种检测小麦矮腥黑粉菌的试剂盒及方法
NZ602056A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2013066369A2 (en) Methods for detecting graft-versus-host disease
Zhao et al. Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination
CN102399753B (zh) 一种小麦矮腥黑粉菌的特异性单克隆抗体及免疫荧光检测方法
JP2014502848A5 (cg-RX-API-DMAC7.html)
CN106520771B (zh) 一种长非编码rna及其在诊断/治疗子痫前期中的应用
Chouchane et al. Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2
JP2008502332A5 (cg-RX-API-DMAC7.html)
WO2006116442A3 (en) Monoclonal antibodies and methods for their use in the detection of cervical disease
Rha et al. SARS-CoV-2 spike-specific nasal-resident CD49a+ CD8+ memory T cells exert immediate effector functions with enhanced IFN-γ production
Wei et al. Ultrasensitive “Hunter of Target”: Rabbit Monoclonal Antibody-Based Competitive Lateral Flow Immunoassay for Saxitoxin
JP2008500833A5 (cg-RX-API-DMAC7.html)
IL190401A0 (en) Antibodies against april as biomarkers for early prognosis of lymphoma patients
EP2768969B1 (en) Detection of viable endophyte
WO2010035259A3 (en) Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll
WO2024103504A1 (zh) 一种检测炎症相关疾病的标志物和方法
CN110669818A (zh) 多发性骨髓瘤肠道微生物标志物及应用和检测制剂
GB2568617A (en) Specific monoclonal antibodies of the antigen M of the human metapneumovirus (HMPV), and use thereof in a diagnostic method
JP5864918B2 (ja) オートタキシンアイソフォーム特異的抗体および検出方法
CN101709087A (zh) 一种小麦叶锈菌单克隆抗体及其制备方法与应用
CN102268409B (zh) 一种抗人蛋白rn181的单克隆抗体及杂交瘤细胞株3952与试剂盒
IN2012DN02304A (cg-RX-API-DMAC7.html)